12:00 AM
 | 
Sep 16, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Rosetta Genomics sales and marketing update

Rosetta said U.S. healthcare preferred provider organization (PPO) network providers FedMed Inc. and Fortified Provider Network (FPN) will cover Rosetta's Cancer Origin Test. Rosetta declined to disclose the reimbursement rates for the test. The company said more than...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >